Transcriptional changes in blood after aerobic interval training in patients with the metabolic syndrome

European Journal of Preventive Cardiology

Volumn 16, Issue 1, 2009, Pages 47-52

  Bye, Anja ^a   Tjã¸nna, Arnt E ^a   Stã¸len, Tomas O ^a   Rã¸sbjã¸rgen, Ragnhild E n ^a   Wislã¸ff, Ulrik ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

cell adhesion molecules; endothelial function; microarray; nitric oxide; RNA

Indexed keywords

ACYLTRANSFERASE; AMINO ACID; ANION CHANNEL; ARGINASE 1; CELL ADHESION MOLECULE; COMPLEMENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN RECEPTOR; KRUPPEL LIKE FACTOR 6; RIBOSOME PROTEIN; RNA; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; STEROID HORMONE; VON WILLEBRAND FACTOR; ARGINASE; STEROID;

AEROBIC CAPACITY; AEROBIC EXERCISE; ARTICLE; BLOOD ANALYSIS; BLOOD CELL; BLOOD CLOTTING; CARDIOVASCULAR RISK; CATABOLISM; CLINICAL ARTICLE; COENZYME; CYTOKINESIS; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HEALTH PROGRAM; HUMAN; INSULIN SENSITIVITY; KINESIOTHERAPY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; RNA EXTRACTION; RUNNING; SIGNAL TRANSDUCTION; STEROID METABOLISM; TRANSCRIPTION REGULATION; TREADMILL EXERCISE; UPREGULATION; WALKING; BLOOD; CELL ADHESION; DNA MICROARRAY; EXERCISE; ISOLATION AND PURIFICATION; METABOLISM; TRANSCRIPTION INITIATION;

ARGINASE; BLOOD COAGULATION; CELL ADHESION; DOWN-REGULATION; EXERCISE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; SIGNAL TRANSDUCTION; STEROIDS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; VON WILLEBRAND FACTOR;

EID: 65649126375     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32831c13a0     Document Type: Article

References (36)

1. World Health Organisation. Report of a WHO consultation: definition of the metabolic syndrome, diagnosis, and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus. Geneva: WHO Department of Noncommunicable Disease Surveillance: 1999.
2. Morris PJ, Packianathan CI, Van Blerk CJ, Finer N. Moderate exercise and fibrinolytic potential in obese sedentary men with metabolic syndrome. Obes Res 2003; 11: 1333–1338.
3. Katzmarzyk PT, Leon AS, Wilmore JH, Skinner JS, Rao DC, Rankinen T, et al Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. Med Sci Sports Exerc 2003; 35: 1703–1709.
4. Hoydal MA, Wisloff U, Kemi OJ, Britton SL, Koch LG, Smith GL, et al Nitric oxide synthase type-1 modulates cardiomyocyte contractility and calcium handling: association with low intrinsic aerobic capacity. Eur J Cardiovasc Prev Rehabil 2007; 14: 319–325.
5. Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, et al Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome. A pilot study. Circulation 2008; 118: 346–354.
6. Batliwalla FM, Li W, Ritchlin CT, Xiao X, Brenner M, Laragione T, et al Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol Med 2005; 11: 21–29.
7. Bomprezzi R, Ringner M, Kim S, Bittner ML, Khan J, Chen Y, et al Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet 2003; 12: 2191–2199.
8. Shephard RJ. Adhesion molecules, catecholamines and leucocyte redistribution during and following exercise. Sports Med 2003; 33: 261–284.
9. Bo TH, Dysvik B, Jonassen I. LSimpute: accurate estimation of missing values in microarray data with least squares methods. Nucleic Acids Res 2004; 32: e34.
10. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–5121.
11. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545–15550.
12. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115.
13. Haram PM, Adams V, Kemi OJ, Brubakk AO, Hambrecht R, Ellingsen O, et al Time-course of endothelial adaptation following acute and regular exercise. Eur J Cardiovasc Prev Rehabil 2006; 13: 585–591.
14. Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, et al Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003; 26: 2119–2125.
15. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S, et al Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 2003; 108: 2000–2006.
16. Spector EB, Rice SC, Kern RM, Hendrickson R, Cederbaum SD. Comparison of arginase activity in red blood cells of lower mammals, primates, and man: evolution to high activity in primates. Am J Hum Genet 1985; 37: 1138–1145.
17. Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, et al Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107: 3152–3158.
18. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, et al Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle. Circulation 2005; 111: 1763–1770.
19. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, et al Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007; 115: 3086–3094.
20. Michiels C. Endothelial cell functions. J Cell Physiol 2003; 196: 430–443.
21. van Oostrom AJ, van Wijk JP, Sijmonsma TP, Rabelink TJ, Castro Cabezas M. Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes. Neth J Med 2004; 62: 320–325.
22. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 1998; 83: 224–229.
23. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, et al Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002; 295: 505–508.
24. McCubbin JA, Heifer SG, Switzer FS III, Price TM. Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease. Am Heart J 2002; 143: 711–717.
25. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89: 1501–1510.
26. PEPI-Trial TWGft. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1995; 273: 199–208.
27. Sumino H, Ichikawa S, Itoh H, Utsugi T, Ohyama Y, Umeda M, et al Hormone replacement therapy decreases insulin resistance and lipid metabolism in Japanese postmenopausal women with impaired and normal glucose tolerance. Horm Res 2003; 60: 134–142.
28. Kingwell BA. Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J 2000; 14: 1685–1696.
29. Fagard RH, Cornelissen VA. Effect of exercise on blood pressure control in hypertensive patients. Eur J Cardiovasc Prev Rehabil 2007; 14: 12–17.
30. Eckel RH. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD. Proc Nutr Soc 2007; 66: 82–95.
31. Womack CJ, Nagelkirk PR, Coughlin AM. Exercise-induced changes in coagulation and fibrinolysis in healthy populations and patients with cardiovascular disease. Sports Med 2003; 33: 795–807.
32. Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997; 34: 255–265.
33. Lufkin EG, Fass DN, O'Fallon WM, Bowie EJ. Increased von Willebrand factor in diabetes mellitus. Metabolism 1979; 28: 63–66.
34. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102–1108.
35. Chong AY, Blann AD, Patel J, Freestone B, Hughes E, Lip GY. Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation 2004; 110: 1794–1798.
36. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, et al Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 1993; 328: 1069–1075.